Michael Hoffman is an accomplished Executive Director of Medical Writing at Incyte since March 2020, with a strong background in managing medical writing teams across various therapeutic areas including CNS/Neuromuscular, Ophthalmology, and Rare Diseases. Previously, Michael served as Head of Global Medical Writing at Takeda and Shire Pharmaceuticals, where a focus on global medical writing strategies was paramount. Michael's career includes significant roles at Genzyme Sanofi as Head of Medical Writing, and a Senior Director position at United BioSource Corporation. Earlier experience encompasses clinical safety at Parke-Davis/Pfizer and positions at Pfizer and Parke Davis. Michael holds a Doctorate in Science, Public Health from Tulane University and the Tulane University Celia Scott Weatherhead School of Public Health and Tropical Medicine.
This person is not in any teams
This person is not in any offices